Company: CCIXW
Filing Date: 2025-12-05
Form Type: S-4/A
Source: 0001193125-25-309933
Chunk: 266

Company: Churchill Capital Corp IX/Cayman
Filing Date: 2025-12-05
Form: S-4/A
Chunk 266
---
 pursuant to Regulation S-K 601;

waive, release, compromise, settle or satisfy any pending or threatened material claim, action or proceeding or compromise or settle any liability;

establish a new subsidiary or enter into a new line of business;

voluntarily fail to maintain in full force and effect its director and officer liability insurance policy in a form and amount consistent with past practices (except that the CCIX shall be authorized to replace existing insurance policies with substantially comparable amounts of insurance coverage);

incur, guarantee or otherwise become liable for any indebtedness or make a loan or advance to or investment in any third party (other than certain permitted Working Capital Loans);

adopt or enter into a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization of CCIX or its subsidiaries (other than the Merger and the transactions contemplated by the Merger Agreement); and

offer, issue, deliver, grant or sell, or authorize or propose to offer, issue, deliver, grant or sell, any capital stock of, other equity interests, equity equivalents, stock appreciation rights, stock units, phantom stock ownership interests or similar rights in, CCIX or any of its subsidiaries or any securities convertible into, or any rights, warrants or options to acquire, any such capital stock or equity interests except for certain permitted Working Capital Loans or as expressly contemplated by the Merger Agreement.

The Merger Agreement also contains additional covenants of the parties, including, among other things, covenants providing for:

the parties to prepare and file this proxy statement/prospectus and to solicit proxies from CCIX shareholders to vote on the proposals that will be presented for consideration at the extraordinary general meeting;

compliance with the notification and reporting requirements under the HSR Act;

mutual exclusivity during the interim period between signing of the Merger Agreement and Closing;

each party to take certain actions to effect the intended tax treatment of the Transactions;

<div align='center'>152</div>

the protection of confidential information of the parties and, subject to the confidentiality requirements, the provision of reasonable access to information;

the parties to take all necessary action to cause the Post-Closing Company Board to consist of seven or nine directors, who shall include (1) two directors designated by the Sponsor (one of which to be designated as a Class II director and one of which to be designated as a Class III director) and (2) such other individuals determined by PlusAI, in its sole and exclusive discretion, subject to applicable law and stock